Needham & Company LLC Has Lowered Expectations for Vir Biotechnology (NASDAQ:VIR) Stock Price
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective decreased by investment analysts at Needham & Company LLC from $19.00 to $14.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective suggests a potential upside of […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective decreased by investment analysts at Needham & Company LLC from $19.00 to $14.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective suggests a potential upside of […]
